Evidence map›Paper›PMID 35318537›Full record

ReviewMagma (New York, N.Y.)2022

High resolution magic angle spinning MRS in prostate cancer.

Matteo Sanchez-Dahl Gonzalez, Isabella H Muti, Leo L Cheng

Abstract readReview
PubMed Publisher
In one paragraph

Review in Magma (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. NMR-based metabolomics: Where are we now and where are we going?Progress in nuclear magnetic resonance spectroscopy
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matteo Sanchez-Dahl GonzalezMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Isabella H MutiMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Leo L ChengMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA. lcheng@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-5975-5406
Harvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProstate cancer (PCa) is one of the leading causes of death among men worldwide. The current methods utilized to screen for prostate cancer may not have sufficient sensitivity in distinguishing aggressive from indolent diseases, which affect the quality of life of patients in the short and long term. The overdiagnosis of cases and overtreatment are prevalent due to the heterogeneity of the disease in terms of latent and progressive variants, as well as in the tissue types present in biopsy samples.

methodsThe purpose of this review is to discuss the potential clinical benefits of incorporating high-resolution magic angle spinning (HRMAS) magnetic resonance spectroscopy (MRS) modalities to overcome the current challenges in the diagnosis, prognostication, and monitoring of PCa.

Indexed as

Magnetic Resonance SpectroscopyProstatic NeoplasmsHumansMaleHigh-resolution magic angle spinning magnetic resonance spectroscopyMagnetic resonance spectroscopyMetabolomicsProstate cancerReview

Identifiers

PMID35318537
OpenAlexW4221017240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.